ADVERTISEMENT

Rash Decisions

Educational campaign launched to help nurses help patients who have treatment-related rash. 

BY MELISSA WEBER
PUBLISHED WEDNESDAY, MAY 20, 2009
Talk about this article with other patients, caregivers, and advocates in the General Discussions CURE discussion group.
No one has had smallpox since the 1970s, but that’s exactly what Thailand authorities feared  when a recent patient of Edith Mitchell, MD, tried boarding a flight with red lesions covering his face. Airport officials put the man in quarantine—a big fuss for a guy who merely had a skin rash caused by his cancer treatment.

When the Food and Drug Administration approved the first EGFR inhibitor a handful of years ago, little was known about the skin rashes that can develop as a side effect in up to 90 percent of patients. The drugs target the epidermal growth factor receptor, found on the surface of some cancer cells. But EGFR can also be found on normal skin cells, causing the kind of unsightly sores that may not land a patient in quarantine but leave them feeling just as isolated and embarrassed.

“Not only does [rash] detract from the person’s self-confidence and their quality of life, but also it could lead to treatment interruptions and delays,” says Mitchell, a gastrointestinal cancers specialist from Philadelphia’s Kimmel Cancer Center at Thomas Jefferson University.

Mitchell is involved with “Coping with Cancer from the Outside In,” an educational campaign launched by Amgen and ONSEdge, a subsidiary of the Oncology Nursing Society. The project was launched at the ONS annual meeting in late April.

EGFR inhibitors currently approved to treat cancer include Erbitux (cetuximab) for colorectal and head and neck cancer; Vectibix (panitumumab) for colorectal cancer (Amgen makes Vectibix); Tarceva (erlotinib) for lung and pancreatic cancer; Nexavar (sorafenib) for liver and kidney cancer; Sutent (sunitinib) for gastrointestinal stromal tumor and kidney cancer; and Tykerb (lapatinib) for HER2-positive breast cancer.

Mitchell says helping patients understand skin-related side effects and how to manage them starts with educating nurses—especially since nurses are sometimes the only people who can get patients to really open up.

Beth Zubal, RN, a nurse practitioner involved with the campaign, says patients sometimes don’t talk about side effects they experience because they don’t want to disappoint the physician. “They want to continue and be persistent with therapy. So, many times, they feel like they can have that dialogue maybe with a nurse,” says Zubal, of Washington University’s Siteman Cancer Center in St. Louis.

Patients might also keep quiet when skin changes develop because they’re happy to see the rash. Research has found that patients who develop a rash may be more likely to benefit from treatment, but it’s a correlation Mitchell is quick to clarify. “It doesn’t mean that everybody who has a rash will have an anti-tumor response. It’s simply a statistical phenomenon.” Plus, she adds, if left untreated, rash can lead to serious infections that can be life-threatening.



Mitchell was among the researchers involved in testing EGFR inhibitors in clinical trials. The first patient she treated had a tremendous response to the drug but developed a severe rash. “I wasn’t ready to accept the fact that patients have to put up with this rash.”

Talk about this article with other patients, caregivers, and advocates in the General Discussions CURE discussion group.
ADVERTISEMENT
Cure Connections
Related Articles
Pneumonitis: A Delayed Reaction
Pneumonitis, a lung inflammation, often appears months after the cancer treatment that sparked it.
20 Inspirational Quotes for Cancer Survivors, Fighters and Caregivers
Keeping a positive outlook is proven to help with stress management, but when someone says to "think positive" or "be optimistic" during a time such as cancer, it can be much easier said than done.
Giving Caregivers a Hand
BY MELISSA SILVERBERG
A variety of social media apps can lighten the workload for caregivers by making it easier to recruit help from friends and family.
Time Management Techniques for Caregivers
BY MELISSA SILVERBERG
Facing myriad responsibilities both new and old, caregivers can benefit from time management techniques.
Non-Physician Practitioners Playing Larger Roles in Cancer Care
BY MELISSA QUINTERO
In the face of a shortage of oncologists, non-physician practitioners are playing larger roles on cancer-care teams.
Related Videos
Gwendolyn P. Quinn on the Need to Educate Health Care Providers on Reproductive Health
BY GWENDOLYN P. QUINN
Gwendolyn P. Quinn, member, Moffitt Cancer Center, comments on the need to educate all health care providers — especially those caring for patients with cancer — on sexual and reproductive health.
Hope Rugo on Managing Sexual Dysfunction From Ovarian Suppression
BY HOPE S. RUGO
Hope S. Rugo discusses managing sexual dysfunction from ovarian suppression treatment for breast cancer.
Hope Rugo on Managing Effects From Ovarian Suppression in Patients With Breast Cancer
BY HOPE S. RUGO
Hope S. Rugo discusses managing effects from ovarian suppression treatment for breast cancer.
Leslie R. Schover on Sexuality After Cancer Treatment
BY LESLIE R. SCHOVER
Leslie R. Schover, professor of behavioral science, The University of Texas MD Anderson Cancer Center, discusses information and education for patients regarding sexuality after treatment.
Leslie R. Schover on Male Issues After Cancer Treatment
BY LESLIE R. SCHOVER
Leslie R. Schover, professor of behavioral science, The University of Texas MD Anderson Cancer Center, discusses some problems men face after cancer treatment.
$auto_registration$